Table 1 Sociodemographic characteristics of the study population
Variables | All patients N = 80,517 | Patients with no homecare n = 64,886 | Patients receiving homecare n = 15,631 | P-value Homecare vs. no homecare |
|---|---|---|---|---|
Aged (year) Median (IQR) | 75 (70–82) | 74 (70–80) | 83 (76–88) | < 0.001 |
Marital status (married) | 43,498 (54%) | 39,725 (62%) | 3773 (24%) | < 0.001 |
Sex (female) | 40,882 (51%) | 30,918 (48%) | 9964 (64%) | < 0.001 |
In treatment for mental disorders | 27,517 (34%) | 19,243 (30%) | 8274 (53%) | < 0.001 |
In treatment with * | ||||
Antipsychotics | 1696 (2%) | 1078 (2%) | 618 (4%) | < 0.001 |
Anxiolytics | 4311 (5%) | 3125 (5%) | 1186 (8%) | < 0.001 |
Hypnotics & sedative | 9069 (11%) | 6740 (10%) | 2329 (15%) | < 0.001 |
Antidepressants | 6706 (8%) | 4558 (7%) | 2148 (14%) | < 0.001 |
Medicine for dementia | 1272 (2%) | 628 (1%) | 644 (4%) | < 0.001 |
Income after taxes (Euro) | ||||
median (IQR) | 22,162 (17,756–29,300) | 22,323 (17,513–30,435) | 21,801 (18,710–25,796) | < 0.001 |
Charlson Comorbidity Index | ||||
median (IQR) | 0 (0–2) | 0 (0–1) | 1 (0–2) | < 0.001 |
0 | 48,548 (60%) | 41,358 (64%) | 7190 (46%) | |
1 | 10,066 (12%) | 7414 (11%) | 2652 (17%) | |
2 | 13,562 (17%) | 10,418 (16%) | 3144 (20%) | |
> 3 | 8341 (11%) | 5696 (9%) | 2645 (17%) | |
Mortality | ||||
< 30 days | 3010 (4%) | 1790 (3%) | 1220 (8%) | < 0.001 |
< 180 days | 7022 (9%) | 4320 (7%) | 2702 (17%) | < 0.001 |
< 360 days | 10,191 (13%) | 6.325 (10%) | 3866 (25%) | < 0.001 |
Readmission | ||||
< 7 days | 5371 (7%) | 4094 (6%) | 1277 (8%) | < 0.001 |
< 30 days | 10,895 (14%) | 8127 (13%) | 2768 (18%) | < 0.001 |